You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR ATOMOXETINE HYDROCHLORIDE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for ATOMOXETINE HYDROCHLORIDE

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00029614 ↗	Atomoxetine to Treat Adolescents With Coexisting Alcohol and Other Substance Use Disorder and ADHD	Completed	National Institute on Alcohol Abuse and Alcoholism (NIAAA)	Phase 2	2006-05-01	The purpose of this study is to compare the effectiveness and safety of atomoxetine in the treatment of adolescents with coexisting alcohol or substance use disorders and Attention Deficit Hyperactivity Disorder (ADHD).
NCT00029614 ↗	Atomoxetine to Treat Adolescents With Coexisting Alcohol and Other Substance Use Disorder and ADHD	Completed	University of Pittsburgh	Phase 2	2006-05-01	The purpose of this study is to compare the effectiveness and safety of atomoxetine in the treatment of adolescents with coexisting alcohol or substance use disorders and Attention Deficit Hyperactivity Disorder (ADHD).
NCT00089869 ↗	A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia	Completed	Eli Lilly and Company	Phase 1/Phase 2	1969-12-31	Study of a medication for the treatment of Schizophrenia in patients who are already taking Abilify, Risperdal, Seroquel, Zyprexa
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for ATOMOXETINE HYDROCHLORIDE

Condition Name

Chart
Table

Condition Name for ATOMOXETINE HYDROCHLORIDE
Intervention	Trials
Attention Deficit Hyperactivity Disorder	66
ADHD	15
Attention Deficit Disorder With Hyperactivity	15
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for ATOMOXETINE HYDROCHLORIDE
Intervention	Trials
Attention Deficit Disorder with Hyperactivity	103
Hyperkinesis	81
Disease	58
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for ATOMOXETINE HYDROCHLORIDE

Trials by Country

Map
Table

Trials by Country for ATOMOXETINE HYDROCHLORIDE
Location	Trials
United States	403
Canada	22
United Kingdom	19
Germany	15
Spain	14
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for ATOMOXETINE HYDROCHLORIDE
Location	Trials
New York	27
California	24
Massachusetts	18
Florida	18
Texas	16
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for ATOMOXETINE HYDROCHLORIDE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for ATOMOXETINE HYDROCHLORIDE
Clinical Trial Phase	Trials
Phase 4	59
Phase 3	35
Phase 2/Phase 3	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for ATOMOXETINE HYDROCHLORIDE
Clinical Trial Phase	Trials
Completed	133
Not yet recruiting	14
Recruiting	12
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ATOMOXETINE HYDROCHLORIDE

Sponsor Name

Chart
Table

Sponsor Name for ATOMOXETINE HYDROCHLORIDE
Sponsor	Trials
Eli Lilly and Company	69
National Institute on Drug Abuse (NIDA)	13
National Institute of Mental Health (NIMH)	9
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for ATOMOXETINE HYDROCHLORIDE
Sponsor	Trials
Other	140
Industry	98
NIH	34
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.